Cabozantinib + Rifampin Interaction

Moderateinteraction on record

Description

Strong CYP3A4 inducer that decreased cabozantinib exposure by 77%. Avoid chronic co-administration or increase COMETRIQ dosage if unavoidable.

Mechanism

CYP3A4 induction

Source: NLP:cabozantinib